35 / 160
35
Springer, 2008, pp 154–180.
5. Langston C: New concepts in the pathology of congenital lung
malformations. Semin Pedi- atr Surg 2003;12:17–37.
6. Adzick NS, Harrison MR, Crombleholme TM, Flake AW, Howell
LJ: Fetal lung lesions: management and outcome. Am J Obstet
Gynecol 1998;179:884–889.
7. Correia-Pinto J, Gonzaga S, Huang Y, Rottier R: Congenital
lung lesions.underlying molecular mechanisms. Semin Pediatr
Surg 2010;19:171–179.
8. Wilson RD, Hedrick HL, Liechty KW, Flake AW, Johnson MP,
Bebbington M, et al: Cystic adenomatoid malformation of
the lung: review of genetics, prenatal diagnosis, and in utero
treatment. Am J Med Genet A 2006;140: 151–155.
9. Langston C: New concepts in the pathology of congenital lung
malformations. Semin Pediatr Surg 2003;12:17–37.
10. Witlox RS, Lopriore E, Oepkes D, Walther FJ. Neonatal outcome
after prenatal interventions for congenital lung lesions. Early
Hum Dev. 2011;87(9):611–618.
11. Cavoretto P, Molina F, Poggi S, Davenport M, Nicolaides KH.
Prenatal diagnosis and outcome of echogenic fetal lung
lesions. Ultrasound Obstet Gynecol. 2008;32(6):769–783.
12. Khalek N, Johnson MP. Management of prenatally diagnosed
lung lesions. Semin Pediatr Surg. 2013;22(1):24–29.
13. Witlox RS, Lopriore E, Oepkes D: Prenatal interventions for fetal
lung lesions. Prenat Diagn 2011;31:628–636.
14. Yong PJ, Von Dadelszen P, Carpara D, et al. Prediction of
pediatric outcome after prenatal diagnosis and expectant
antenatal management of congenital cystic adenomatoid
malformation. Fetal Diagn Ther. 2012;31(2):94–102.
15. Crombleholme TM, Coleman B, Hedrick H, et al. Cystic
adenomatoid malformation volume ratio predicts outcome in
prenatally diagnosed cystic adenomatoid malformation of the
lung. J Pediatr Surg. 2002;37(3):331–338. 1
16. Morotti RA, Cangiarella J, Gutierrez MC, Ja- girdar J, Askin F,
Singh G, et al: Congenital cystic adenomatoid malformation
of the lung (CCAM): evaluation of the cellular compo- nents.
Hum Pathol 1999;30:618–625.
17. Morotti RA, Gutierrez MC, Askin F, Profitt SA, Wert SE, Whitsett
JA, et al: Expression of thyroid transcription factor-1 in
congenital cystic adenomatoid malformation of the lung.
Pediatr Dev Pathol 2000;3:455–461.
18. Cass DL, Quinn TM, Yang EY, Liechty KW, Crombleholme TM,
Flake AW, et al: Increased cell proliferation and decreased
apoptosis characterize congenital cystic adenomatoid
malformation of the lung. J Pediatr Surg 1998;33:1043–
1046; discussion 1047.
19. Liechty KW, Crombleholme TM, Quinn TM, Cass DL, Flake
AW, Adzick NS: Elevated platelet-derived growth factor-B
in congenital cystic adenomatoid malformations requiring
fetal resection. J Pediatr Surg 1999;34: 805–809; discussion
809–810. .
20. Fromont-Hankard G, Philippe-Chomette P, Delezoide AL,
Nessmann C, Aigrain Y, Peuchmaur M: Glial cell-derived
neurotrophic factor expression in normal human lung and
congenital cystic adenomatoid malformation. Arch Pathol Lab
Med 2002;126:432–436.
21. Wagner AJ, Stumbaugh A, Tigue Z, Edmondson J, Paquet
AC, Farmer DL, et al: Genetic analysis of congenital cystic
adenomatoid malformation reveals a novel pulmonary
gene: fatty acid binding protein-7 (brain type). Pediatr Res
2008;64:11–16.
22. Volpe MV, Pham L, Lessin M, Ralston SJ, Bhan I, Cutz E, et al:
Expression of Hoxb-5 during human lung development and in
con- genital lung malformations. Birth Defects Res A Clin Mol
Teratol 2003;67:550–556.
23 Gontan C, de Munck A, Vermeij M, Gros- veld F, Tibboel D,
Rottier R: Sox2 is impor- tant for two crucial processes in lung
development: branching morphogenesis and epithelial cell
differentiation. Dev Biol 2008; 317:296–309.
24. Gonzaga S, Henriques-Coelho T, Davey M, Zoltick PW, Leite-
Moreira AF, Correia-Pinto J, et al: Cystic adenomatoid
malformations are induced by localized FGF10 overexpression
in fetal rat lung. Am J Respir Cell Mol Biol 2008;39:346–355.
25. Kline-Fath B, Bitters C: Prenatal imaging of fetal lung lesions:
magnetic resonance imaging complements ultrasound. J
Radiol Nurs 2010;29:3–9.
26. Epelman M, Kreiger PA, Servaes S, Victoria T, Hellinger JC:
Current imaging of prenatally diagnosed congenital lung
lesions. Semin Ul- trasound CT MR 2010;31:141–157.
27. Laje P, Liechty KW: Postnatal management and outcome
of prenatally diagnosed lung lesions. Prenat Diagn
2008;28:612–618.
28. Bush A, Hogg J, Chitty LS: Cystic lung lesions prenatal diagnosis
and management. Prenat Diagn 2008;28:604–611.
29. Morris LM, Lim FY, Livingston JC, Polzin WJ, Crombleholme TM:
High-risk fetal congenital pulmonary airway malformations
have a variable response to steroids. J Pediatr Surg
2009;44:60–65.
30. Curran PF, Jelin EB, Rand L, et al. Prenatal steroids for
microcystic congenital cystic adenomatoid malformations. J
Pediatr Surg. 2010;45(1):145–150.
31. Tsao K, Hawgood S, Vu L, et al. Resolution of hydrops fetalis
in congenital cystic adenomatoid malformation after prenatal
steroid therapy. J Pediatr Surg. 2003;38(3):508–510.
32. Endoscopic Surgery in Infants and Children Editors: Klaas
M. A. Bax MD, PhD, FRCS, Keith E. Georgeson MD, Steven S.
Rothenberg MD, Jean-Stéphane Valla MD, PhD, C K Yeung
MD, PhD ISBN: 978-3-540-00115-7 (Print) 978-3-540-
49910-7 (Online).
33. David M, Lamas-Pinheiro R, et al. Prenatal and Postnatal
Management of Congenital Pulmonary Airway Malformation.
Portugal Neonatology 2016;110:101–115.
34. Hellmund A, Berg Ch, et al. Prenatal Diagnosis and Evaluation
of Sonographic Predictors for Intervention and Adverse
Outcome in Congenital Pulmonary Airway Malformation. PLOS
ONE March 15, 2016
35. Kapralik J, Wayne C, Chan E, Nasr A.Surgical versus conservative
management of congenital pulmonary airway malformation
[ENFOQUE ACTUAL DE LAS MALFORMACIONES PULMONARES - Dra. Mónica Saavedra y col.]